ARTICLE | Company News
Amoy Diagnostics, Illumina deal
November 2, 2015 8:00 AM UTC
Amoy will develop and commercialize oncology related tests based on Illumina’s next-generation sequencing (NGS) technology, including TruSight Tumor 15, in China. TruSight Tumor 15 is an NGS-based tes...